BioSpace News Archive

DMK Pharmaceuticals Corporation today announced that the compensation committee of the board of directors approved the grant of a stock option on October 23, 2023, to purchase an aggregate of 70,000 shares of common stock to John W. Dorbin, Jr., a newly hired employee who was appointed as General Counsel and Corporate Secretary of the company.

Reviva Pharmaceuticals Holdings, Inc. today announced positive topline results and successful completion of its pivotal Phase 3 RECOVER trial evaluating the efficacy, safety and tolerability of once-daily brilaroxazine, a serotonin-dopamine signaling modulator in adults with schizophrenia.

Dyne Therapeutics, Inc. today reported financial results for the third quarter of 2023 and provided an update on progress and upcoming milestones for its Phase 1/2 ACHIEVE and DELIVER clinical trials.

Redwire Corporation announced today the first spaceflight mission for its cutting-edge in-space pharmaceutical manufacturing platform, PIL-BOX, designed to offer pharmaceutical companies and researchers novel and flexible services to grow small-batch crystals of protein-based pharmaceuticals and other key pharmaceutically relevant molecules for research.

Cabaletta Bio, Inc. announced that the Company will participate in three upcoming investor conferences in November.

Bitterroot Bio has been selected to present research at the upcoming American Heart Association Scientific Sessions conference, which will take place from November 11-13, 2023 at the Pennsylvania Convention Center in Philadelphia, PA.

Enovis™ Corporation announced it will showcase the latest technologies from its Surgical business, including an updated ARVIS® Augmented Reality System, EMPOWR™ blade stem, and EMPOWR 3D Knee® at the American Association of Hip and Knee Surgeons annual meeting in Grapevine, Texas, November 2-5, 2023.

Catalyst Pharmaceuticals, Inc. announced that Catalyst will participate in the upcoming 11th Annual Epilepsy Awareness Day & Education Expo, taking place at the Disneyland Hotel in Anaheim, CA, October 30-31, 2023, to raise awareness and education with the epilepsy community.

STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that the Board of Directors and Bob Moccia have mutually agreed that Mr. Moccia will step down as the Company’s Chief Executive Officer and member of the Board, as of October 30, 2023.

BeyondSpring Inc. announced that on October 27, 2023, it received a written notification from the Listing Qualifications Department from The Nasdaq Stock Market LLC that the Company has regained compliance with the minimum bid price requirement set forth in Rule 5550 of the Nasdaq Listing Rules.